q fohmen No, 001/SDG-AHM/1/2019 Jakarta, 14 January 2018 To: Mr. Djagad Prakasa Dwialam Chief Operating Officer PT. Anugerah Pharmindo Lestari Cowell Tower, 10° FI Jl. Senen Raya No. 135 Jakarta Dear Sir, As per your recommendation, J&J will provide B2B interventions for |& strategic hospitals below for period December ~ February 2019. This intervention will be for all J& products in APL (ETHICON, ETHICON Endo Surgery, ASP, Biosense Webster and Depuy). 1. RS Cipto Mangunkusumo —Jakarta 2. SUP Fatmawati — Jakarta 3. RSUP Persahabatan Jakarta 4. RSPAD Gatot Subroto — Jakarta 5. RS Hasan Sadikin ~ Bandung, 6. RSUD Dr Soetomo — Surabaya 7. RSAL Ramelan ~ Surabaya 8. RSUP Sanglah — Denpasar 9. RS Wahidin ~ Makassar 10. RS AWS ~Samarinda 11. RSUP Prof Kandou ~ Manado 12. RSUP Dr M Hoesin ~ Palembang 13. RSUD Dr Achmad Mochtar ~ Bukit Tinggi 14, RSUD Arifin Achmad ~ Pekanbaru 15, RSUD Raden Mattaher — Jambi 16. RSUD Cengkareng — Jakarta 17. RS Polri Kramat Jati - Jakarta That list can be changed after 3 months. Both J&| and APL will review them at the end of 34 month. With that, we are hoping there won't be any challenges in near futures Thank you for your kind attention. Yours Sipderely, Bussiness Unit Head PT. dohnon & Johnson indonesia Link Tower J Gatet Subrcto No, S00, T2ihFlorsakarta Seltan 12960, Indonesia “Tlephone €2-2) 29953035 Facsimlo (6221) 9046-32248,